Fintech PR
Scaling Global Resilience: New Report Highlights Increasing Momentum for Evidence-backed Solutions
- The Resilience Evidence Forum (REF) 2023 Synthesis Report released, serving as a comprehensive guide to resilience-building methodologies and evidence.
- The report underscores the pivotal role of high-quality evidence both in mobilising the large-scale financing needed and informing and catalysing the policy changes essential for building resilience.
- The Report summarises key discussions held at the June 2023 Resilience Evidence Forum, co-hosted by USAID and the Global Resilience Partnership, which brought together more than 1,000 global stakeholders to evaluate the state of resilience evidence.
NEW YORK, Sept. 19, 2023 /PRNewswire/ — In a world grappling with escalating crises—from conflict and pandemics to the dire impacts of climate change—never has resilience been more critical. Released today, the REF 2023 Synthesis Report sets a new benchmark as an unmatched guide to resilience-building methodologies and evidence. The report recognises resilience as the ability to recover from and adapt to shocks and stresses, while enabling longer-term, systemic transformations, and offers actionable insights to inform investment, policy, and decision-making.
Through summarising the key discussions held at the REF in Cape Town, the report underscores the imperative to build on progress, address gaps, recognise various forms of evidence, and prioritise resilience as a collective goal.
Evidence of successful resilience implementation spans different sectors, stakeholders, and geographies – from the strengthening of small-holder farmers and grower communities’ resilience through radical cross-sector collaboration to the role of climate smart agriculture that combines seed technologies, soil fertility, and innovative financial tools for farmers. Taken together, the evidence detailed in the report showcases the increasing magnitude of resilience building initiatives globally.
However, scaling these evidence-based solutions requires a significant increase in finance. Annual spending on climate resilience alone is less than $50 billion, a mere fraction of the estimated $160 billion to $340 billion required. The private sector contributes just 2% to this insufficient pool, making resilience gains fragile and susceptible to setbacks like those witnessed during the COVID-19 pandemic.
To unlock further funding for resilience programming at the scale needed, the report concludes, evidence needs to be relevant and actionable. This also stands true for policy and decision-making; evidence must not only be rigorous and reliable, but also apply to the policies and decisions it seeks to influence. This will require collaborative action from donors, the private sector, policy makers, governments, community-based organisations and leaders, and research organisations to satisfy evidence needs, avoid duplication of efforts, and focus resources and investments.
In parallel, the report demonstrates the importance of diverse evidence – including that which is grounded in local experience and knowledge – to fortify global resilience efforts in the face of increasing threats and to connect local realities with global goals.
“Without equitable, radical collaboration and commitment to evidence that informs decision-making, policy, and investment,, we will continue to face barriers in protecting and supporting environments and communities that can flourish even in the face of change and uncertainty. The Resilience Evidence Forum was a significant moment for taking stock of where we are and where we need to go in strengthening resilience.” – Dr Nathanial Matthews, Chief Executive Officer, Global Resilience Partnership
Co-hosted by USAID and the Global Resilience Partnership, REF was the first such occasion in five years, convening more than 1,000 individuals from the private sector to universities to NGOs and local community groups. As well as a focus on how to further resilience programming, REF and the Synthesis Report highlights case studies and resilience success stories. These offer insight into the interventions that have worked and serve to guide future interventions. Examples of these success stories can be found in Appendix 1.
“With climate and other shocks becoming more frequent, severe and overlapping, there is an urgency to getting smarter, faster in terms of knowing what works when it comes to building resilience. At USAID we will continue to promote convenings like the Forum, to learn more about what others are doing and learning, and promote collaboration and partnership needed to drive equitable growth and well-being in an increasingly unpredictable world.”– Dina Esposito, Feed the Future Deputy Coordinator for Development and USAID Global Food Crisis Coordinator
“It is very important that the stories of resilience get told in the language of those impacted the most and that we learn to work with those stories, pull out what we need from that and don’t take a top-down approach to resilience evidence.” – Dr Shehnaaz Moosa, Director, SouthSouthNorth
Appendix 1
Slum Dwellers International (SDI)’s Know Your City long-standing profiling programme has helped debunk assumptions about informal settlements through community organising and the collection of household-level slum enumeration. For example, since 2017, residents of Mukuru — one of the largest informal settlements in Nairobi, Kenya — undertook an ambitious, groundbreaking participatory upgrading process, the Mukuru Special Planning Area (SPA). Led by the Kenya Slum Dwellers Federation, this process organised over 1,000 groups in 21 cities and towns to take part in a community-led enumeration process. This was then used to inform the development of the area-based upgrading plan.
SERVIR, a collaborative initiative between NASA, USAID, and leading technical organisations, leverages satellite data to address pressing challenges in food security, water resources, weather and climate, land use, and natural disasters in Asia, Africa, and the Americas. This partnership correlates satellite observations with ground data in regions like Ethiopia, Niger, and Zimbabwe, effectively measuring resilience from space by assessing the efficacy of development interventions (e.g.,halfmoon constructions for rain retention and soil improvement). The transparent and objective nature of satellite data supports evidence-based decision-making, thereby bolstering sustainability efforts in vulnerable regions.
Under the Grown for Good Framework, world-leading spice and flavour producers McCormick & Company aim to increase the resilience of over 35,000 farmers by 2025 This is measured by increasing skills and capacity, income, access to financial services, education, and nutrition and health,. This is achieved through multiple interventions – from purchasing higher-value cured vanilla beans from the growing communities, rather than raw, that give farmers a higher purchase price, to investing in infrastructure for remote communities such as the vanilla-growing communities in Madagascar, and building or rehabilitating local schools and libraries, giving children from farming families improved access to education.
Notes to Editors
The Global Resilience Partnership (GRP) is made up of 70+ organisations that work together to advance resilience through identifying and scaling on the ground innovation, generating and sharing knowledge, and shaping policy. GRP envisages an inclusive world in harmony with nature, that is better prepared to cope with shocks, adapt to change, and transform – all within planetary boundaries. The Partnership is registered as a non-profit organisation in South Africa and co-hosted by the Stockholm Resilience Centre at Stockholm University.
For media enquiries, please contact Isobel Turnill at Browning Environmental Communications – [email protected], +44 (0) 7585151035
View original content:https://www.prnewswire.co.uk/news-releases/scaling-global-resilience-new-report-highlights-increasing-momentum-for-evidence-backed-solutions-301931099.html
STOCKHOLM, April 5, 2024 /PRNewswire/ — EQT AB’s Q1 Announcement 2024 will be published on Thursday 18 April 2024 at approximately 07:30 CEST. EQT will host a conference call at 08:30 CEST to present the report, followed by a Q&A session.
The presentation and a video link for the webcast will be available here from the time of the publication of the Q1 Announcement.
To participate by phone and ask questions during the Q&A, please register here in advance. Upon registration, you will receive your personal dial-in details.
The webcast can be followed live here and a recording will be available afterwards.
Information on EQT AB’s financial reporting
The EQT AB Group has a long-term business model founded on a promise to its fund investors to invest capital, drive value creation and create consistent attractive returns over a 5 to 10-year horizon. The Group’s financial model is primarily affected by the size of its fee-generating assets under management, the performance of the EQT funds and its ability to recruit and retain top talent.
The Group operates in a market driven by long-term trends and thus believes quarterly financial statements are less relevant for investors. However, in order to provide the market with relevant and suitable information about the Group’s development, EQT publishes quarterly announcements with key operating numbers that are relevant for the business performance (taking Nasdaq’s guidance note for preparing interim management statements into consideration). In addition, a half-year report and a year-end report including financial statements and further information relevant for investors is published. Finally, EQT also publishes an annual report including sustainability reporting.
Contact
Olof Svensson, Head of Shareholder Relations, +46 72 989 09 15
EQT Shareholder Relations, [email protected]
Rickard Buch, Head of Corporate Communications, +46 72 989 09 11
EQT Press Office, [email protected], +46 8 506 55 334
This information was brought to you by Cision http://news.cision.com
https://news.cision.com/eqt/r/invitation-to-presentation-of-eqt-ab-s-q1-announcement-2024,c3956826
The following files are available for download:
|
Invitation to presentation of EQT AB’s Q1 Announcement 2024 |
|
|
https://news.cision.com/eqt/i/eqt-ab-group,c3285895 |
EQT AB Group |
View original content:https://www.prnewswire.co.uk/news-releases/invitation-to-presentation-of-eqt-abs-q1-announcement-2024-302109147.html
- Kia drives forward transformation into ‘Sustainable Mobility Solutions Provider’
- Roadmap enables Kia to proactively respond to uncertainties in mobility industry landscape, including changes in EV market
- Company to expand EV line-up with more models; enhance HEV line-up to manage fluctuation in EV demand
- Goal to sell 1.6 million EVs annually in 2030, introducing 15 models
- PBV to play a key role in Kia’s growth, targeting 250,000 PBV sales annually by 2030 with PV5 and PV7 models
- Kia to invest KRW 38 trillion by 2028, including KRW 15 trillion for future business
- 2024 business guidance : KRW 101 tln in revenue with KRW 12 tln in operating profit; operating profit margin of 11.9% on sales of 3.2 million units globally
- CEO reaffirms Kia’s commitment to ESG management
SEOUL, South Korea, April 5, 2024 /PRNewswire/ — Kia Corporation (Kia) today shared an update on its future strategies and financial targets at its CEO Investor Day in Seoul, Korea.
Based on its innovative achievements in the years since the announcement of mid-to-long-term business initiatives, Kia is focusing on updating its 2030 strategy announced last year and further strengthening its business strategy in response to uncertainties across the global mobility industry landscape.
During the event, Kia updated its mid-to-long-term business strategy with a focus on electrification, and its PBV business. Kia reiterated its 2030 annual sales target of 4.3 million units, including 1.6 million units of electric vehicles (EVs). The 2030 4.3 million annual sales target is 34.4 percent higher than the brand’s 2024 annual goal of 3.2 million units.
The company also plans to become a leading EV brand by selling a higher percentage of electrified models among its total sales, including hybrid electric vehicles (HEV), plug-in hybrid (PHEV), and battery EVs, projecting electrified model sales of 2.48 million units annually or 58 percent of Kia’s total sales in 2030.
“Following our successful brand relaunch in 2021, Kia is enhancing its global business strategy to further the establishment of an innovative EV line-up and accelerate the company’s transition to a sustainable mobility solutions provider,” said Ho Sung Song, President and CEO of Kia. “By responding effectively to changes in the mobility market and efficiently implementing mid-to-long-term strategies, Kia is strengthening its brand commitment to the wellbeing of customers, communities, the global society, and the environment.”
Photo – https://mma.prnewswire.com/media/2380039/Photo_1__2024_CEO_Investor_Day.jpg
PDF – https://mma.prnewswire.com/media/2380040/Press_Release__2024_Kia_CEO_Investor_Day_240405.pdf
View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/kia-presents-roadmap-to-lead-global-electrification-era-through-evs-hevs-and-pbvs-302109142.html
VANCOUVER, BC, April 4, 2024 /PRNewswire/ — BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) (the “Company“) is providing this bi-weekly update on the status of the management cease trade order granted on February 29, 2024 (the “MCTO“), by its principal regulator, the Ontario Securities Commission (the “OSC“), under National Policy 12-203 – Management Cease Trade Orders (“NP 12-203“), following the Company’s announcement on February 21, 2024 (the “Default Announcement“), that it was unable to file its audited annual financial statements for the year ended October 31, 2023, its management’s discussion and analysis of financial statements for the year ended October 31, 2023, its annual information form for the year ended October 31, 2023, and related filings (collectively, the “Required Annual Filings“). Under National Instrument 51-102, the Required Annual Filings were required to be made no later than February 28, 2024.
As a result of the delay in filing the Required Annual Filings, the Company was unable to file its interim financial statements for the three months ended January 31, 2024, its management’s discussion and analysis of financial statements for the three months ended January 31, 2024, and related filings (collectively, the “Required Interim Filings“). Under National Instrument 51-102, the Required Interim Filings were required to be made no later than April 1, 2024.
The Company anticipates filing the Required Annual Filings by April 30, 2024. The auditor of the Company requires additional time to complete its audit of the Company, including the Company’s recent acquisition of all intellectual property, immunotherapeutics platform technologies, and clinical stage assets of the former IMV Inc. that closed on February 16, 2024. In addition, the Company anticipates filing the Required Interim Filings immediately after the filing of the Required Annual Filings.
Except as herein disclosed, there are no material changes to the information contained in the Default Announcement. In addition, (i) the Company is satisfying and confirms that it intends to continue to satisfy the provisions of the alternative information guidelines under NP 12-203 and issue bi-weekly default status reports for so long as the delay in filing the Required Annual Filings and/or Required Interim Filings is continuing, each of which will be issued in the form of a press release; (ii) the Company does not have any information at this time regarding any anticipated specified default subsequent to the default in filing the Required Annual Filings and Required Interim Filings; (iii) the Company is not subject to any insolvency proceedings; and (iv) there is no material information concerning the affairs of the Company that has not been generally disclosed.
About BioVaxys Technology Corp.
BioVaxys Technology Corp. (www.biovaxys.com), a biopharmaceuticals company registered in British Columbia, Canada, is a clinical-stage biopharmaceutical company dedicated to improving patient lives with novel immunotherapies based on the DPX™ immune-educating technology platform and it’s HapTenix© ‘neoantigen’ tumor cell construct platform, for treating cancers, infectious disease, antigen desensitization, and other immunological fields. The Company’s clinical stage pipeline includes maveropepimut-S which is in Phase II clinical development for advanced Relapsed-Refractory Diffuse Large B Cell Lymphoma (DLBCL) and platinum resistant ovarian cancer, and BVX-0918, a personalized immunotherapeutic vaccine using it proprietary HapTenix© ‘neoantigen’ tumor cell construct platform which is soon to enter Phase I in Spain for treating refractive late-stage ovarian cancer. The Company is also capitalizing on its tumor immunology know-how and creation of a unique library of T-lymphocytes & other datasets post-vaccination with its personalized immunotherapeutic vaccines to utilize predictive algorithms and other technologies to identify new targetable tumor antigens. BioVaxys common shares are listed on the CSE under the stock symbol “BIOV” and trade on the Frankfurt Bourse (FRA: 5LB) and in the US (OTCQB: BVAXF). For more information, visit www.biovaxys.com and connect with us on X and LinkedIn.
ON BEHALF OF THE BOARD
Signed “James Passin“
James Passin, Chief Executive Officer
Phone: +1 646 452 7054
Logo – https://mma.prnewswire.com/media/1430981/BIOVAXYS_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/biovaxys-technology-corp-provides-bi-weekly-mcto-status-update-302108920.html
-
Latest News6 days ago
China remains stabilizing force for global economic growth
-
Latest News4 days ago
Martello Re announces closing of $1.3 billion capital raise consisting of $935 million in equity and a $360 million upsize of the Company’s credit facility
-
Latest News5 days ago
Kylian Mbappé and Accor Forge Alliance to Empower Younger Generations
-
Latest News5 days ago
Market Dojo Celebrates Prestigious Inclusion in Ardent Partners 2024 Strategic Sourcing Technology Advisor
-
Latest News5 days ago
BioCatch completes best first half in company history, grows ARR by 43% YoY
-
Latest News2 days ago
Driving Innovation Forward: CFI Welcomes Seven-Time Formula 1™ World Champion Lewis Hamilton as new Global Brand Ambassador
-
Latest News5 days ago
COP28 President calls on all stakeholders to bring spirit of solidarity that delivered UAE Consensus to drive implementation and sustainable socio-economic development
-
Latest News2 days ago
KEYSTONE BANK HOLDS CUSTOMER FORUM, REITERATES COMMITMENT TO EXCELLENT SERVICE DELIVERY